<DOC>
	<DOCNO>NCT01966276</DOCNO>
	<brief_summary>The Synergy Trial evaluate safety efficacy currently available medication ( methylphenidate hydrochloride ) combine CFS-specific dietary supplement ( CFS Nutrient Formula ) treat Chronic Fatigue Syndrome ( CFS ) .</brief_summary>
	<brief_title>The Synergy Trial : Methylphenidate Plus CFS-Specific Nutrient Formula Treatment Chronic Fatigue Syndrome</brief_title>
	<detailed_description>The Synergy Trial evaluate safety efficacy currently available medication ( methylphenidate ) combine CFS-specific dietary supplement ( CFS Nutrient Formula ) treat Chronic Fatigue Syndrome ( CFS ) . The CFS Nutrient Formula use trial broad-spectrum micronutrient supplement provide CFS patient vitamin , mineral , cofactor ( amino acid , antioxidant , mitochondrial cofactor ) complement low-dose Central Nervous System ( CNS ) stimulant ( methylphenidate ) . In word , therapeutic dosage micronutrient provide support function nervous , endocrine , immune system level low customary dosage methylphenidate produce positive clinical effect CFS symptom also well tolerate . Methylphenidate generic form Ritalin® . The dose test study relatively low ( 5-10mg twice daily ) . This drug clinical use 50 year treatment Narcolepsy Attention Deficit Disorder well-described safety profile use recommend . Methylphenidate alone study treatment CFS past show produce mild benefit well-tolerated . When provided innovative therapy , methylphenidate plus CFS Nutrient Formula produce substantial improvement CFS symptom limit number patient , demonstrate excellent tolerability . Use low dose methylphenidate hydrochloride coadministered CFS Nutrient Formula previously evaluate controlled clinical study . The risk patient use combination believe low , especially context well-controlled clinical study . Furthermore , combination expect increase incidence severity adverse event associate methylphenidate hydrochloride .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Encephalomyelitis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Subjects must fulfill 1994 CDC case definition CFS ( Fukuda et al. , Ann Intern Med . 1994 ; 121:953959 ) Subjects must also report alertness and/or concentration deficit Otherwise good health base medical history screen evaluation Willingness NOT take nutritional herbal supplement study treatment course trial Nutritional supplement exempt requirement limit follow : Probiotic supplement Fiber supplement Fish oil supplement Digestive enzyme Melatonin ≤ 10mg per day Calcium ≤ 600 mg per day Magnesium ≤ 400 mg per day Vitamin D ≤ 400 i.u . per day Willingness NOT consume caffeinecontaining supplement study period ( coffee , tea , chocolate exempt ) . These include limited following beverage : Red Bull® Monster® Rockstar® 5hour® energy shot Willingness NOT consume pseudoephedrinecontaining product study period Willingness practice effective contraception Pregnancy lactation Active substance abuse Major depression define Zung Depression Scale score ≥ 60 Use rintatolimod ( Ampligen® ) within past 3 month Currently take prescription medication treat anxiety daily basis Use 3 times/week within past 3 month : Monoamine oxidase inhibitor ( MAOs ) Antipsychotic medication CNS stimulant ( i.e . Provigil® , Nuvigil® , Adderall® , Ritalin® , amphetamine ) Narcotic opioids Tramadol ( i.e . Ultram® , Ultracet® , Conzip® , Ryzolt® ) Gabapentin ( Neurontin® ) &gt; 600mg/day Pregabalin ( Lyrica® ) Duloxetine ( Cymbalta® ) Milnacipran ( Savella® ) Coumarin anticoagulant ( Coumadin® ) Valganciclovir ( Valcyte® ) Daily concurrent use one antidepressant medication except one two antidepressant medication : Amitriptyline ≤ 30mg bedtime Trazodone ≤ 50mg bedtime Doxepin ≤ 20mg bedtime Active medical condition treatment methylphenidate hydrochloride micronutrient may contraindicate , include : Glaucoma Diabetes Mellitus Current stomach duodenal ulcer Uncontrolled hypertension ( blood pressure screen systolic &gt; 150 diastolic &gt; 90 ) Heart disease ( include cardiac arrhythmia , cardiac ischemia , syndrome Gilles de la Tourette past history myocardial infarction cerebrovascular event ) Motor tic family history psychosis bipolar disorder Previous history seizures A diagnosis condition may part responsible patient 's fatigue include , limited : HIV infection Chronic Hepatitis B &amp; C Cancer ( receive treatment either currently within past two year ) Chronic Renal Disease Clinically significant laboratory test value determine Investigator Clinically significant ECG abnormality determine Medical Monitor Compliance criterion : A subject eligible he/she , opinion Investigator , unable comply aspect study protocol , include visit schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Chronic Fatigue Syndrome ( CFS )</keyword>
	<keyword>Myalgic Encephalomyelitis ( ME )</keyword>
	<keyword>central nervous system ( CNS )</keyword>
	<keyword>fatigue</keyword>
	<keyword>alertness</keyword>
	<keyword>brain fog</keyword>
	<keyword>mitochondrion</keyword>
	<keyword>methylphenidate</keyword>
	<keyword>Ritalin</keyword>
	<keyword>stimulant</keyword>
	<keyword>multivitamin</keyword>
	<keyword>multimineral</keyword>
	<keyword>micronutrient</keyword>
	<keyword>supplement</keyword>
</DOC>